Johnson & Johnson closes $2bn LifeScan sale
Johnson & Johnson (J&J) has closed the $2.1billion sale of its LifeScan blood glucose monitoring subsidiary to private equity player Platinum Equity. The sale is part of the
Johnson & Johnson (J&J) has closed the $2.1billion sale of its LifeScan blood glucose monitoring subsidiary to private equity player Platinum Equity. The sale is part of the
The new addition to Lifescan’s OneTouch stable of blood glucose meters is the OneTouch Verio. Boasting unsurpassed accuracy, especially on low blood glucose readings, this